Data Breach

ExecuPharm Data Breach Investigation

Posted on

Migliaccio & Rathod is currently investigating pharmaceutical firm ExecuPharm for failure to adequately safeguard employees’ private information, resulting in a data breach. On March 13th, an unknown third party deployed ransomware to ExecuPharm’s IT systems, seeking to extract payment in return for an encryption key. As part of the cyberattack, ExecuPharm employees were sent phishing […]

Product Defect

Metformin Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the widely used diabetes drug metformin, known by the common brand names Glucofage, Riomet, and Glumetza, for product contamination. Online pharmacy Valisure tested various metformin batches for impurities containing N-nitrosodimethylamine, or NDMA, a probable human carcinogen, and found sixteen contaminated batches. One batch contained sixteen times […]

Product Defect

Ranitidine Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the prescription and over-the-counter heartburn medication ranitidine, known by the brand name Zantac. The U.S. Food and Drug Administration (FDA) recently requested manufacturers pull the drug from the market, citing an ongoing investigation that found many ranitidine samples contained hazardous levels of the contaminant NDMA, a […]